Product Information
DOXYCYCLINE HYC DR 100 MG TAB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $2.1836 per EA under NDC 62332048231. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jan 3, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332048231
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Generic (ANDA)
FDA Application
ANDA213075FDA Approved
1/3/2022
TE Code
AB
On Market Since
1/4/2022
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYC DR 100 MG TAB has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1836 per EA |
|---|---|
| All-time high | $2.3668 (Jun 10, 2026) |
| All-time low | $1.6502 (Sep 18, 2024) |
| 52-week high | $2.3668 |
| 52-week low | $1.7822 |
| Median price | $1.8664 |
| Average price | $1.9519 |
| Largest weekly change | -15.7% (Jun 19, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline Hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYC DR 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYC DR 100 MG TAB, manufactured by Alembic Pharmaceuticals Inc., is $2.1836 per EA (NDC 62332048231), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYC DR 100 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYC DR 100 MG TAB has declined 3.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYC DR 100 MG TAB?
Since Apr 17, 2024, the NADAC for DOXYCYCLINE HYC DR 100 MG TAB has ranged from a low of $1.6502 (Sep 18, 2024) to a high of $2.3668 (Jun 10, 2026), with a median of $1.8664 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYC DR 100 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXYCYCLINE HYCLATE 100 MG TAB, is $0.1180 per EA — about 95% below DOXYCYCLINE HYC DR 100 MG TAB.
Who manufactures DOXYCYCLINE HYC DR 100 MG TAB?
DOXYCYCLINE HYC DR 100 MG TAB (NDC 62332048231) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.